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Abstract
Substance use correlates of depressive symptoms among incarcerated adult male African 
American substance users were examined in the current study. Frequency of drug use was assessed 
with 12 items specific to an individual’s substance use. The Patient Depression Questionnaire 
(PHQ-9) was used to assess symptoms of depression. Approximately 90% of the sample displayed 
symptoms of depression ranging from minimal to severe. Regression models revealed that three 
substance use variables demonstrated a significant predictor of depression, including alcohol (β = .
16, p= .03), hallucinogens (β = − .17, p =.021), and ecstasy (β = − .14, p= .05). The study findings 
indicate a need to consider the role of specific substances with regard to symptoms of depression. 
The results are discussed in the context of transition planning for jail inmates.
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There are more than 2.3 million people incarcerated in jails and prisons in the United States 
(U.S.).1 African Americans are disproportionately represented in the criminal justice system. 
In 2013, African Americans represented 13.1% of the general population, yet 36% of the 
national jail population.2,3 One in three Black males are likely to be imprisoned during their 
lifetime as compared to one in six Hispanics and one in seventeen Whites.4,5
There are various reasons for the disproportionate representation of African Americans in 
the criminal justice system, including poverty and disparate sentencing. Changes in policies, 
specifically “the war on drugs”⋆ has resulted in mass incarceration targeting individuals with 
drug offenses.5 Unfortunately, racial and socioeconomic disparities exist among the 
incarcerated, as low-income predominantly non-White communities are targeted by the 
policies enacted.6,7 Two-thirds of all persons in prison for drug offenses are people of color.5
In addition to socioeconomic and racial disparities, health disparities also exist among 
inmates. Inmates have a higher burden of chronic diseases, as well as mental illness than the 
general population.6–8 Although large numbers of individuals remain undiagnosed, some 
estimates suggest 14.8% of federal inmates, 25.5% of state inmates, and 25% of county jail 
inmates had at least one mental illness diagnosis.9 Others have suggested ranges of mental 
illness occurrence among incarcerated populations to be between 6% and 53.7%.10 
According to the Bureau of Justice Statistics,11 64% of jail inmates had a mental health 
problem. Of those with mental health problems, 26% had multiple arrests, 76% had 
substance dependence or abuse, and 63% had used drugs in the month prior to their most 
recent arrest. Among jail inmates, African Americans do not experience a greater burden of 
mental illness than Whites, yet they do experience differences in treatment in the community 
prior to arrest.12 African American jail inmates were found to be less likely to report 
receiving mental health treatment prior to arrest compared with White inmates.12 However, 
when provided with access to treatment while incarcerated, there were no differences in 
utilization of treatment between African American and White jail inmates.12 It would stand 
to reason that race-related differences in treatment persist once an inmate is released from 
jail and returns to their community because the same barriers to access to treatment are 
present or may even be exacerbated due to the stigma of incarceration.
Incarcerated individuals eventually return to the community. Approximately eight million 
people are released from jails and prisons every year in the U.S.13 Although past research 
has primarily focused on the over 500,000 annually released from prisons, attention has 
recently expanded to the roughly seven million people being released from jails.13 Jails 
⋆The term war on drugs has been used in the U.S. since the early 1970s when it was taken as short-hand for the Nixon 
Administration’s campaign for policies making or keeping most recreational drugs illegal as well as conducting military operations 
and providing military support to slow or halt the drug trade internationally (briefly, policies of eradication, interdiction, and 
incarceration). In recent years, it has fallen into some disuse due to critiques of its (in)effectiveness and implicit characterization of 
drug addiction as a crime rather than a disease, as well as questions raised about the relative harmfulness of various banned 
substances. —Eds.
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represent a unique challenge because the incarceration period is shorter and people often 
cycle in and out of jail. Individuals diagnosed with a mental illness are frequently singled 
out for special attention in reentry discussions, in part because it is believed that they are at 
greater risk of recidivism than those without mental illness.14–16 Previous studies have 
documented connections among mental illness, substance use, and recidivism.11,17,18 
Inmates with a history of substance abuse are at greater risk for mental illness compared 
with those who do not have a history of substance abuse.19 Specifically, those with a history 
of substance abuse had more suicide attempts, and higher scores for psychoticism and 
neuroticism, as measured by the Eysenck Inventory.19 Depressive symptoms are also 
correlated with a co-occurring substance abuse disorder among inmates.20 Incarcerated 
individuals who have been shown to exhibit dual diagnosis of a major psychiatric disorder 
and a substance abuse disorder have a much higher risk of parole revocation.21 For those 
with mental illness, recidivism rates are significantly higher during the first year of parole 
than for those without psychiatric disorder,16 and rates were as high as 34% in a sample of 
parolees attending outpatient psychiatric clinics.22 Wilson and colleagues23 examined 
recidivism patterns over a four-year period for individuals admitted to a large U.S. urban jail 
system and found individuals readmitted to the jail with a mental illness diagnosis alone had 
the lowest number of readmissions to jail in the four years after release, with 50% having at 
least one readmission after their initial release. In contrast, individuals diagnosed with 
mental illness and substance abuse had the highest number of readmissions to jail, with 68% 
having at least one readmission during the four years after release.
Consequently, for substance abusers who start the addiction recovery process in prison, re-
entering society can offer additional distinct challenges compared with the general 
population,24 particularly if they have a history of mental health issues.
Two-thirds of individuals in the general population with depressive symptoms remain 
undiagnosed.25 Depression is the leading cause of disability for individuals ages 15–44 years 
in the U.S.26 In those over age 18, estimates range from 6.7% to 7.9% of the total U.S. 
population having a major depressive disorder in a given year, translating into over 14 
million adults who are living with major depression in the U.S.3,11,27 Due to the multiple 
risk factors previously noted, an incarcerated population may exhibit more symptoms of 
depression than the general population. In contrast, estimates from jail inmates range from 
25% to 30% of these individuals meeting the criteria for major depressive disorder.11,28,29 
However, there remains limited research investigating possible co-morbid depression and 
substance abuse among incarcerated populations. Limited information is available as to 
whether specific substances, if any, affect the rate of depression among incarcerated 
populations. The studies cited previously are limited with regard to the consideration of 
specific substances used by inmates that may be associated depression symptoms. The 
current study sought to examine substance use correlates of depressive symptoms in a 
sample of African American male jail inmates. While African American males are 
overrepresented among incarcerated populations, studies examining drug use and mental 
health have not specifically addressed African Americans. The findings from the current 
study may have implications in effectively planning for adult African American male jail 
inmates transitioning back into the community by identifying specific substances that are 
correlates for depressive symptoms.
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Participants were recruited from an urban Southern jail as part of a larger study examining 
sexual risk-taking behaviors and re-entry. Eligible jail inmates were adult African-American 
males, sexually active, with a self-reported history of substance abuse, and who would be 
released in 90 days or less. The length of stay in the jail ranged from 24 hours to two years, 
with an average stay of two weeks. Research staff worked with jail personnel to identify 
eligible inmates from among those currently housed at the facility. Participants were first 
approached by the research staff and provided with a spoken description of the study. 
Interested inmates were assessed for study eligibility, and if they met the eligibility criteria, 
they were consented and administered a baseline survey. Due to the length of stay in the 
facility, some participants provided consent and were surveyed after their release from the 
facility. These were participants who were usually incarcerated for 48 hours or less. A total 
of 320 participants were screened and approached for study recruitment. Of those, 203 
(63.4%) were enrolled in the study (completing both the consent and baseline 
questionnaire). A total of 87 (27.2%) participants refused to participate or did not complete 
the enrollment process. During the consent process, participants were informed that 
participation in the study would have no bearing on their incarceration.
Participants were provided a $15.00 gift card as an incentive for completing the baseline 
survey. The incentive was distributed after release from the facility, by a peer educator. All 
surveys were administered face-to-face in a private location either within the jail or in the 
community by a member of the research team. The survey took approximately one hour to 
complete. The study was approved by the institution’s Institutional Review Board (IRB).
Outcome measures
Socio-demographic and control variables—The baseline questionnaire included 
items to assess socio-demographic and other background characteristics of participants. Age, 
marital status, as well as educational, residential, and incarceration history were assessed 
and included in analyses for this study.
Frequency of drug use—Frequency of drug use in the three months prior to 
incarceration was assessed with a research lab-developed, 12-item instrument, specific to an 
individual drug. These items were used to identify and to yield a quantitative index score of 
the degree of drug usage. The response scale ranged from 1 = “daily” to 5 = “once a month.” 
Respondents who indicated “never” using each specified drug were coded as a “0.”
Depression—The PHQ-9 Patient Depression Questionnaire30 was used to assess an 
inmate’s symptoms of depression. Total scale scores could range from 0–27, with scores 
categorized as follows: minimal depression = 1–4; mild depression = 5–9; moderate 
depression = 10–14; moderately severe depression = 15–19; severe depression = 20–27.
Data analysis
The data were analyzed using Statistical Predictive Analytic Software 18 (PASW, formerly 
known as SPSS). Descriptive statistics were used to characterize the socio-demographic 
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attributes of the study sample. Bivariate correlations were conducted among all study 
variables. The variables that were significant at the bivariate level were retained for 
multivariate analyses. Relationships between individual age and substance use variables 
were examined using multiple linear regression models. All models specified self-reported 
substance use regarding a specific indicator of depressive symptomology from the scaled 
items as an outcome with substance use (e.g., alcohol, cocaine, crack) as predictor variables. 
All measures were entered independently into the estimated equations.
Results
Results are provided for 203 study respondents. Inmates ranged from 21 to 66 years of age 
with the overall mean age of participants in the sample being 43.4 years (SD = 9.96 years). 
Approximately 38% had graduated high school or obtained their GED followed by 34.1% 
self-identified as having not completed high school. The majority were single (76.7%) and 
70.4% reported an average annual income less than $10,000 prior to their recent 
incarceration. Almost one-third (31.7%) of participants reported they lived in a shelter, 
rooming house or hotel; 26.9% reported living in their family’s home or apartment; and 
9.9% were homeless prior to incarceration. Additional information on the demographic 
profile of the sample is presented in Table 1.
Lifetime alcohol and marijuana use was reported by the vast majority of respondents. Of 
those who responded, 99.5% (n = 199) had used alcohol in their lifetime and 98.0% (n = 
196) had used marijuana in their lifetime. The mean age of first alcohol use was 14.57 years 
(SD = 4.41) and for marijuana was 15.0 years (SD = 3.21). Approximately 12% (n = 23) 
reported injection drug use without a doctor’s prescription. The frequency of substance use 
in the three months prior to the current incarceration was highest for alcohol, marijuana, 
crack cocaine and powdered cocaine. Alcohol use, once a week or more, was reported by 
79.4% (n = 158) of respondents. Marijuana use, once a week or more, was reported by 
43.7% (n = 86). Crack cocaine and powdered cocaine use, once a week or more, was 
reported by 43.2% (n = 86) and 17.8% (n = 35) of the respondents, respectively.
The range of depression scale scores for the participants were between 0 and 24 with a mean 
score of 7.58 (SD = 6.04). This score indicates mild depression. As detailed in Table 2 and 
determined by the PHQ-9, approximately 11% (n = 21) indicated not experiencing any 
symptoms indicative of depression.
Preliminary bivariate analysis indicated that age was significantly correlated with marijuana 
(r= .38, p<.001) and crack (r=− .23, p<.001) use. Additionally, education was found to be 
significantly correlated with tranquilizer use (r= .14, p=.05). Therefore, age and education 
were included as covariates in their respective regression models. In an effort to isolate age 
as a predictor of depression scale scores, it was regressed on each outcome variable 
independently. Results indicated that age was not a significant predictor of depression scaled 
items. Upon completion of this preliminary analysis, findings from the regression models 
demonstrated that alcohol (β = .16, p = .030), hallucinogens (β = − .17, p = .021), and 
ecstasy (β = − .14, p = .054) were significant predictors of depression and accounted for 
7.1% of the variance in the model. These results are presented in Table 3.
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Estimates suggest that as many as 700,000 of the adults entering jails each year have active 
symptoms of serious mental illness, and that three quarters of these individuals meet criteria 
for a co-occurring addictive disorder.31 The purpose of the current study was to determine 
the extent to which specific use of substances correlated with depression in a sample of 
African American male substance using inmates. Our findings note depressive symptoms, 
ranging from minimal to severe; among 89.5% of study participants who self-reported drug 
use. Self-reported alcohol, hallucinogen, and ecstasy use were significant correlates of 
depression among this sample.
The rates of symptoms of depression endorsed by our sample and significance noted for 
alcohol are not unusual. Although there is a gap in the literature specific to inmate 
populations, a review of the literature suggests a causal link between alcohol use disorders 
and major depression.32 Further, ecstasy users have been found to score higher on the self-
reported Beck Depression Inventory.33,34 An unexpected finding was that cocaine was not 
significant. It has been documented previously that cocaine is associated with the occurrence 
of depression.35–40 We also expected to find that heroin use would be a significant correlate 
of depression, particularly since studies in the past have demonstrated such a correlation 
with other populations41,42 and recently among inmates.43,44
Our findings support the contention offered by Steadman and colleagues45 and Baillargeon, 
et al.14 pertaining to the rates of depression and other serious mental illness present in 
incarcerated populations. The combined rate reported for moderate, moderately severe, and 
severe depression symptoms was 32.4%. Comparatively, previous studies have reported rates 
of depression or other psychiatric disorders ranging from 21.4% to 53.7%.28,46,47
Although our sample overwhelmingly endorsed depressive symptoms, it is difficult to 
determine the actual impact that specific substance use had on depressive symptoms in this 
inmate population. Future studies may consider the exploration of other depressive 
symptoms and their associations to specific substance abuse variables. Future studies may 
also expand the scope to symptoms of other mental illnesses, such as anxiety.
A limitation of this study concerns the possibility of biased reporting. Inmates may falsely 
report perceptions and beliefs, based on the general nature of self-report survey instruments. 
The main focus of the parent study was not mental health; thus, a more comprehensive 
assessment instrument was not used and depression was not confirmed with a clinical 
interview. Another limitation is that information about previous treatment for either mental 
health or substance use was not collected. Given the high level of recidivism in the sample, 
information about participants prior treatment in the community and in the correctional 
facility would be useful in determining if a gap exists in their treatment between jail and the 
community. It is also important to note that participants in this study were incarcerated for 
relatively short periods of time, reflecting the revolving door nature of jails for many 
inmates.
Given all of this, and the nature of the association between depression and substance use, 
more studies among inmates should be conducted in an attempt to add to our knowledge 
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about the relationship between depression, recidivism, and substance use treatment. 
Notwithstanding, it is anticipated that our findings may aid researchers and mental health 
providers within the criminal justice system with addressing mental health and substance use 
issues, particularly as addressing them relates to preparing inmates for transition into the 
community. It is important that those working within the criminal justice system develop 
partnerships with community organizations to address substance use and mental health 
issues to reduce recidivism. Correctional personnel may have limited interaction with many 
jail inmates due to the length of incarcerations. Additionally, due to the length of 
incarceration, mental health treatment may not be available for jail inmates. Having 
information on mental health and specific substance use can aid in identifying appropriate 
community services for inmates upon their release, either by the correctional staff or 
community organizations providing services to jail inmates.
Conclusions
Despite the limitations, findings in this study provide further evidence of the importance of 
both the assessment of mental health problems and the understanding of how specific 
substance use behaviors correlate to mental health problems among jail inmates who will 
eventually be released into the community. This information can be used to assist in 
establishing appropriate treatment services for incarcerated populations, particularly those 
returning to the community. High level of depressive symptoms, as indicated in this study 
sample, may be common in incarcerated populations in general. Hence, mental health 
implications are critical and understanding the etiology of substance use and depression 
could be important to the diagnosis and treatment of depression among incarcerated 
populations in concert with substance abuse treatment.
Even with this small sample, our study findings lend support to the assertion of a need for a 
multifaceted system for prevention and treatment with respect to depression and its 
association with substance use, particularly for African American inmate populations in the 
United States. Moreover, the jail environment may increase the need for mental health 
treatment, especially since the majority of inmates will only be incarcerated for short periods 
of time. In order to serve those returning to the community better and to reduce recidivism, 
the criminal justice system must prioritize the assessment and treatment of mental disorders 
and substance use as part of transition planning.
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Table 1
SOCIODEMOGRAPHIC CHARACTERISTICS (%) OF STUDY PARTICIPANTS (N = 203)
N %
Education
  8th grade or less 12 5.9
  Some high school didn’t finish 57 28.2
  Graduated HS/GED 77 38.1
  Vocational, Trade or Tech. School 16 7.9
  Started College, didn’t finish 31 15.3
  Graduated College 8 4.0
  Started post graduate work 1 0.5
Marital Status
  Married 10 5.0
  Single 155 76.7
  Divorced 22 10.9
  Separated 12 5.9
  Widowed 3 1.5
Income
  Under $10,000 133 70.4
  $10,000–$19,999 28 14.8
  $20,000–$29,999 13 6.9
  $30,000–$39,999 6 3.0
  $40,000–$49,999 4 2.1
  + $50 000 5 2.6
Veteran Status
  Yes 30 17.0
  No 146 83.0
First Time Being Jailed
  Yes 7 3.5
  No 194 96.5
Residency Prior Incarceration
  Own Home/Apartment 38 19.3
  Family’s Home/Apartment 53 26.9
  Others Home/Apartment 22 11.2
  Rooming House/Single Room Hotel 12 6.1
  Shelter 52 25.6
  Homeless 20 9.9
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Table 2
SUMMARY PHQ-9 SCALE CATEGORIES
Category N %
None (0) 21 10.7
Minimal (1–4) 49 25.0
Mild (5–9) 63 32.1
Moderate (10–14) 35 17.8
Moderately Severe (15–19) 23 9.1
Severe (20–27) 11 5.5
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Table 3
PARTICIPANT’S SUBSTANCE USE FOR THE DEPENDENT VARIABLE OF DEPRESSION SCALE 
SCORES
Factor Beta T p
Three Months Before You Were Incarcerated …
  How often used alcohol .612 2.184 .030
  How often used marijuana −.090 −.424 .672
  How often used sedatives/ barbiturates −.224 −412 .681
  How often used tranquilizers −.806 −975 .331
  How often used PCP −1.598 −1.055 .293
  How often used hallucinogens −3.319 −.167 .021
  How often used crack −.042 −.199 .843
  How often used powder cocaine −.534 −1.871 .063
  How often used inhalants −1.509 −1.597 .112
  How often used amphetamines −.733 −.657 .512
  How often used ecstasy 1.147 −1.94 .054
  How often used heroin −.862 −1.533 .127
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